Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) establishes a lifelong latent infection and causes several malignancies in humans. Murine herpesvirus 68 (MHV-68) is a related γ2-herpesvirus frequently used as a model to study the biology of γ-herpesviruses in vivo. The KSHV latency-associated nuclear antigen (kLANA) and the MHV68 mLANA (orf73) protein are required for latent viral replication and persistence. Latent episomal KSHV genomes and kLANA form nuclear microdomains, termed ‘LANA speckles’, which also contain cellular chromatin proteins, including BRD2 and BRD4, members of the BRD/BET family of chromatin modulators. We solved the X-ray crystal structure of the C-terminal DNA binding domains (CTD) of kLANA and MHV-68 mLANA. While these structures share the overall fold with the EBNA1 protein of Epstein-Barr virus, they differ substantially in their surface characteristics. Opposite to the DNA binding site, both kLANA and mLANA CTD contain a characteristic lysine-rich positively charged surface patch, which appears to be a unique feature of γ2-herpesviral LANA proteins. Importantly, kLANA and mLANA CTD dimers undergo higher order oligomerization. Using NMR spectroscopy we identified a specific binding site for the ET domains of BRD2/4 on kLANA. Functional studies employing multiple kLANA mutants indicate that the oligomerization of native kLANA CTD dimers, the characteristic basic patch and the ET binding site on the kLANA surface are required for the formation of kLANA ‘nuclear speckles’ and latent replication. Similarly, the basic patch on mLANA contributes to the establishment of MHV-68 latency in spleen cells in vivo. In summary, our data provide a structural basis for the formation of higher order LANA oligomers, which is required for nuclear speckle formation, latent replication and viral persistence.

Highlights

  • Kaposi sarcoma-associated herpesvirus (KSHV, HHV8), the cause of Kaposi Sarcoma and two lymphoid neoplasms, can persist in a latent form in infected endothelial and B-cells [1]

  • We have solved the crystal structure of the c-terminal, DNAbinding, domain (CTD) of KSHV latencyassociated nuclear antigen (LANA) and its homologue mLANA of a related murine c2-herpesvirus, which is frequently used as a model to study latent persistence in vivo

  • We identified the binding site for two chromatin proteins, BRD2/4, by nuclear magnetic resonance (NMR) spectroscopy

Read more

Summary

Introduction

Kaposi sarcoma-associated herpesvirus (KSHV, HHV8), the cause of Kaposi Sarcoma and two lymphoid neoplasms, can persist in a latent form in infected endothelial and B-cells [1]. The key player in the regulation of KSHV latency is the latencyassociated nuclear antigen (LANA), which is detected in all KSHV infected cells [2,3] and is required for the latent episomal replication of this virus [4,5]. The terminal repeat (TR) region of KSHV contains 20–40 TR elements, which constitute the latent origin of replication [5,6]. The C-terminal domain (CTD) of LANA forms dimers, which bind two adjacent DNA sequences, the LANA binding sites (LBS1 & LBS2) in a single TR [4,7].

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.